{
 "PrintNo":"S2855","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-25T10:24:24.311273Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-25","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"},{"ID":384,"Name":"Joseph P. Addabbo Jr.","Short":"ADDABBO"},
  {"ID":1143,"Name":"Shelley Mayer","Short":"MAYER"},{"ID":416,"Name":"Kevin S. Parker","Short":"PARKER"}
 ],
 "Title":"Provides that a fentanyl analogue shall be deemed to be a schedule I opiate",
 "Summary":"Provides that a fentanyl analogue shall be deemed to be a schedule I opiate.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3302 & 3306, Pub Health L; amd §220.00, Pen L",
 "ActClause":"AN ACT to amend the public health law and the penal law, in relation to fentanyl analogues",
 "SameAsPrintNo":"A4582-2023","PreviousVersions":["S2722-2017","S1652-2019","S1824-2021"]
}